Publication | Open Access

Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients

Tumor BiologyLymphoid NeoplasiaCancer ImmunosurveillanceGastrointestinal OncologyMedicineImmunologyTumor ImmunityPathologyGastric Cancer PatientsImmune SurveillanceEpstein–barr Virus StatusOncologyMismatch RepairCancer Research